Recursion Pharmaceuticals

RXRX

8 Obserwujący

$4.39

+4.77%

$0.20

Obserwuj

14 Sierpień

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

RXRX Fair Price

$8.16

Overvalued by 73.9%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

My Notes

Začít psát

Profile

Recursion Pharmaceuticals is a biotechnology company that utilizes modern technologies such as artificial intelligence and machine learning to discover new therapeutic compounds and potential treatment approaches. The key element of their approach is the use of image processing and data analysis systems to create comprehensive maps of cellular processes. This aims to identify potential targets for drugs and therapeutic substances in the fields of genetics, cellular biology, and diseases.

Feed

There are no posts to show right now.